No differences between patients with Lp-PLA2 < 101 μg/L (T1), 101–138 μg/L (T2) and those with Lp-PLA2 values > 138 μg/L (T3) regarding age (63 ± 10 vs.62 ± 12 vs.61 ± 11 respectively, P = 0.43), male gender (90% vs. 93% vs. 90% respectively, P = 0.44), smoking history (82% vs. 84% vs. 84% respectively, P = 0.91), diabetes mellitus (30% vs. 25% vs. 23% respectively, P = 0.28) and hyperlipidemia (80% vs. 75% vs. 73% respectively, P = 0.25) were observed. This evidence concerns the gene PLA2G7 and hyperlipidemia.